The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The industry rank for Xilio Therapeutics's 14-Day RSI or its related term are showing as below:
XLO's 14-Day RSI is ranked worse than 70.9% of 1574
companies
in the Biotechnology industry
Industry Median: 48.645
vs XLO: 55.41
Competitive Comparison of Xilio Therapeutics's 14-Day RSI
For the Biotechnology subindustry, Xilio Therapeutics's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xilio Therapeutics's 14-Day RSI Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Xilio Therapeutics's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Xilio Therapeutics's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Xilio Therapeutics 14-Day RSI Related Terms
Thank you for viewing the detailed overview of Xilio Therapeutics's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.
Xilio Therapeutics (Xilio Therapeutics) Business Description
Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. Leveraging the GPS platform, they are building a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat cancer. The goal is to overcome the limitations of current I-O therapies by developing products with an improved therapeutic index.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XLO has been successfully added to your